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Abstract
Despite advances in radiation delivery protocols, exposure of normal tissues during the course of radiation therapy remains
a limiting factor of cancer treatment. If the canonical TGF-b/Smad pathway has been extensively studied and implicated in
the development of radiation damage in various organs, the precise modalities of its activation following radiation exposure
remain elusive. In the present study, we hypothesized that TGF-b1 signaling and target genes expression may depend on
radiation-induced modifications in Smad transcriptional co-repressors/inhibitors expressions (TGIF1, SnoN, Ski and Smad7).
In endothelial cells (HUVECs) and in a model of experimental radiation enteropathy in mice, radiation exposure increases
expression of TGF-b/Smad pathway and of its target gene PAI-1, together with the overexpression of Smad co-repressor
TGIF1. In mice, TGIF1 deficiency is not associated with changes in the expression of radiation-induced TGF-b pathway-
related transcripts following localized small intestinal irradiation. In HUVECs, TGIF1 overexpression or silencing has no
influence either on the radiation-induced Smad activation or the Smad3-dependent PAI-1 overexpression. However, TGIF1
genetic deficiency sensitizes mice to radiation-induced intestinal damage after total body or localized small intestinal
radiation exposure, demonstrating that TGIF1 plays a role in radiation-induced intestinal injury. In conclusion, the TGF-b/
Smad co-repressor TGIF1 plays a role in radiation-induced normal tissue damage by a Smad-independent mechanism.
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Introduction
Radiation therapy is one of the most important methods of
curing cancer and more than half of cancer patients will receive
radiotherapy at some stage during the course of their treatment.
New radiotherapy techniques aim to improve the radiation dose
gradient to the target tissues and to reduce the dose to the
surrounding normal tissues at risk. However, radiation-induced
normal tissue toxicity remains a major contributor to complication
after cancer therapy [1]. Radiation injury is a complex process
that occurs in organized tissues orchestrated by mutually de-
pendent cellular lineages as well as a multitude of biologically
active molecules such as growth factors, cytokines and chemokines
[2,3].
The Transforming Growth Factor-b1 (TGF-b1) is a highly
important growth factor among the panel of molecules expressed
in tissues after radiation exposure and TGF-b1 contribution in the
initiation and progression of radiation-induced normal tissue
damage is well documented [4,5]. Several studies have demon-
strated a positive correlation between the severity of radiation
injury and TGF-b1 signal activation. Radiation-induced up-
regulation of TGF-b1 expression levels has been shown in lung
[6], kidney [7], intestine [8], skin [9], liver [10], bladder [11] and
rectum [12]. In addition to TGF-b1 itself, several studies have
shown up-regulation of intracellular effectors of TGF-b1 signaling
and, in particular, the canonical Smad-dependent pathway [12–
14]. TGF-b1 transduces signals by binding to complexes of type I
(ALK1 and ALK5) and type II serine/threonine kinase receptors.
Ligand binding induces phosphorylation of the receptors, which
then activate intracellular signaling via phosphorylation of
receptor R-Smads (Smad2 and Smad3). R-Smad then complex
with Smad4, triggering nuclear translocation and subsequent
regulation of expression of specific target genes [15]. Increased
expression of the TGF-b1 receptors, ALK5 and endoglin [13,16],
Smad mediators, Smad2 and Smad3 [14,17], and increased
expression of TGF-b/Smad target genes such as Plasminogen
Activator Inhibitor type 1 (PAI-1) and Connective Tissue Growth
Factor (CTGF) [13,14,18] were reported after irradiation in vivo
and in vitro. Moreover, skin damage is reduced in Smad3
2/2 mice
following ionizing radiation exposure, suggesting that Smad
signalling contributes to radiation-induced injury [19,20].
If TGF-b1 has been demonstrated to be a key mediator
involved in radiation-induced normal tissue damage, the mecha-
nism by which the TGF-b/Smad signal is activated is not fully
understood. Ubiquitous expression of TGF-b1 imposes a fine
tuning of signal transduction. Smad-mediated signals induced by
TGF-b1 are tightly regulated by negative-feedback mechanisms
via inhibitory Smads (I-Smads) [21] and Smad co-repressors such
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Smads (i.e. Smad6 and Smad7) can inhibit the activation of R-
Smads by competing for type I receptor interaction, and by
recruiting specific ubiquitin ligases, known as Smad ubiquitination
regulatory factor (Smurfs), or phosphatases to the activated
receptor complex, thereby targeting it for proteosomal degrada-
tion or dephosphorylation [24]. Recentlty, particular attention was
paid for the smad co-repressor TGIF1 for its expanding biological
roles in development [25,26], acute myeloid leukemia [27], and
hematopoietic cell proliferation and differentiation [28]. TGIF1 is
a member of the three aminoacid loop extension (TALE) class of
homeodomain proteins that functions both as a co-repressor of the
TGF-b1 pathway and as a competitor of the retinoic acid pathway
[29]. TGF-b1-dependent transcriptional repression by TGIF1 is
mediated by direct competition with the coactivator p300/CBP
for Smad2 interaction, thereby repressing TGF-b1 activated
genes. In addition and independently of TGF-b1 signaling,
TGIF1 exerts intrinsic transcriptional repression by direct DNA
binding through the recruitment of the histone deacetylase
complex, the carboxyl-terminus binding protein complex, and
the Sin3 complex, all of which modify chromatin configuration
and limit the transcription of several target genes [30].
Thus, several recent studies in mouse models of renal fibrosis
strongly suggest that down-regulation of Smad7 or Smad co-
repressors Ski and SnoN expressions leads to an amplification of
TGF-b signaling, which contributes to the progression of
inflammation and fibrosis [31–34]. In the present study, we
hypothesized that TGF-b1 signaling and downstream target genes
could be influenced by modifications of I-Smad and/or Smad co-
repressors expression in response to irradiation. We demonstrate in
vivo in a model of radiation-induced small intestinal damage in
mice and in vitro in a model of endothelial cells that radiation-
induced sustained activation of TGF-b/Smad pathway is not
related to the down regulation of its negative feedback mechan-
isms. Moreover, we show that TGIF1 plays a role in radiation-
induced small intestinal damage independently of the Smad
pathway.
Methods and Materials
Animals and Irradiation Procedure
C57BL/6 mice (named wild type) were purchased from Charles
River Laboratories, TGIF1 knockout mice were maintained on
a C57BL/6J background as previously described thus TGIF1
+/+,
TGIF1
+/2 and TGIF1
2/2 were from the same colony [35].
Genotype was determined by PCR screening (Figure S1). For total
body irradiation (TBI), TGIF1
+/+, TGIF1
+/2 and TGIF1
2/2
mice (n=10 to 12 mice per group) were anesthetized with i.p.
injection of a ketamine/xylazine solution and were exposed to
13 Gy, a radiation dose known to induce gastrointestinal
syndrome, using a
60Cobalt source (dose rate 1.4 Gy.min
21).
Localized intestinal radiation injury was performed by exposure of
an intestinal segment to 19 Gy of radiation. Briefly, TGIF1
+/+,
TGIF1
+/2 and TGIF1
2/2 mice were anesthetized with isoflurane
and a 3-cm-long intestinal segment (10 cm from the ileocecal
valve) was exteriorized and exposed to a single dose of 19 Gy
(
60Co source dose rate 1.2 Gy/minute). Sham irradiation was
performed by maintaining the intestinal segment exteriorized
without radiation exposure. After radiation exposure or sham
irradiation, the exposed segment was returned to the abdominal
cavity and peritoneum/abdominal muscles and skin were
separately closed with interrupted sutures and mice were
euthanized at different times after irradiation. For survival curves,
mice were followed until a clinical ‘‘limit point’’ in accordance
with ethic guidelines, i.e. humanely euthanized when presenting
clinical signs of distress such as prostration, severe weight loss and
dyspnea. For TBI survival curves, mice were monitored twice
a day, included week-ends.
Following localized small intestinal irradiation, intestinal
segments from sham and irradiated mice were harvested and
snap-frozen in liquid nitrogen and stored at 280uC for RNA
isolation. All experiments were conducted in compliance with legal
regulations in France for animal experimentation, and protocols
were approved by the ethics committee for animal experimenta-
tion of the Institute for Radiological Protection and Nuclear Safety
(number P05-09).
Histology and Immunohistochemistry
Five-micrometer-thick sections of mouse small intestinal tissue
were stained with hematoxylin-eosin-saffron for routine histology.
Morphometric analyses were performed using the Visiol@b
TM
2000 image analysis software (Biocom SA, Les Ulis, France). For
each animal, villus height value is the mean of 20 villi measured.
The intraindividual variation was about 10%. Data are presented
as the mean values derived from between 3 and 6 tissue sections
from different mice per group 6 standard error of the mean.
Crypt number was assessed along 1000 mm of longitudinal section.
Data are presented as mean values derived from between 3 and 6
tissue sections from different mice per group 6 standard error of
the mean.
Specimens of normal tissue from patients treated for rectal
adenocarcinoma with preoperative radiotherapy (45 Gy; 2 or
1.8 Gy by fraction) were taken from the irradiated field adjacent to
the tumor and from microscopically normal mucosa distant from
the tumor (about 6 weeks after the last fraction). Formalin-fixed,
paraffin-embedded tissue samples were obtained following in-
stitutional ethics (Gustave Roussy Institute) and French Medical
Research Council guidelines. No consent was required and
sections from tissues patients were obtained retrospectively several
years after surgery and data were analyzed anonymously. Briefly
5-mm sections were incubated with anti-TGIF1 (sc-17800, Santa
Cruz Biotechnology, Heidelberg, Germany). Biotinylated rabbit
anti-mouse IgG and streptavidin/biotinylated-peroxidase kit
(DAKO) were used before revelation by DAB substrate kit (Dako,
Trappes, France) and counterstained with hematoxylin.
Endothelial Cell Culture and Irradiation
Human umbilical vascular endothelial cells (HUVECs) were
purchased from Lonza (Verviers, Belgium) and cultured in EGM-
2-MV medium at 37uC with 5% CO2. Cells were used between
passages 4 and 5 and were irradiated at 2, 10 and 20 Gy with
a
137Cesium source.
RNA Isolation, Reverse Transcription and Real-time PCR
Total RNA was prepared with the total RNA isolation kit
(Rneasy Mini Kit, Qiagen, Valencia, CA). RNA quantification
and integrity was analysed using Agilent 2100 bioanalyzer. RT
was performed with 1 mg RNA using a reverse transcription kit
from Applied Biosystems (Courtaboeuf, France). Pre-developed
TaqMan gene expression assays (Applied Biosystems) were used to
quantify transcript levels of all studied genes (see Table S1). qPCR
was carried out using the ABI PRISM 7900 Sequence detection
system, and the results were normalized to the housekeeping genes
GAPDH or 18S for respectively in vitro or in vivo experiments.
Relative mRNA was quantified using the DDCT method.
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HUVECs were transiently co-transfected with (CAGA)9-Lux
reporter or PAI- Luc plasmids together with myc-Smad3 or myc-
TGIF using FuGENE HD (Roche Diagnostics, Meylan, France).
In all experiments, co-transfection with renilla luciferase pRLTK
vector was used for normalization. 24 hours after transfection,
cells were serum depleted for 18 hours and were irradiated and/or
treated with 10 ng/mL of TGF-b1. The cells were lysed 24 hours
later and relative luciferase activity was measured using a Mithras
luminometer (Berthold Technologies, Bad Wildbad, Germany) by
the Dual-Luciferase reporter assay according the manufacturer’s
instructions (Promega, Charbonnie `res, France).
Western Blot Analysis
Proteins lysed in RIPA buffer supplemented with proteases and
phosphatases inhibitors were separated by SDS-polyacrylamide
gel electrophoresis before transfer onto nitrocellulose membranes.
The following protein-specific primary antibodies were used: anti-
TGIF1 (sc9825), anti-Ski (sc-33693), anti SnoN (sc-9141), anti-
Myc (9E10) (Santa-Cruz Biotechnology), anti-Smad7 (MAB2029,
R&D Systems Europe, Lille, France), anti-PAI-1 (Novocastra
Laboratories Ltd., Newcastle, UK), anti-Smad3 (Zymed), anti-
phospho-Smad3 (C25A9, Cell signaling technology, Danvers,
MA). Membranes were incubated with HRP-conjugated second-
ary antibody (Amersham, Orsay, France) and were developed
using enhanced chemiluminescence (Amersham). Membranes
were stripped and reprobed with anti-glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) antibody (Biodesign, Saco, ME) to
detect GAPDH expression as a loading control.
TGIF Gene Silencing using siRNA
Human TGIF1 siRNA and non-targeting negative control
siRNA (ON-TARGETplus SMARTpool TGIF1 L-011404 and
ON-TARGETplus Non-targeting Pool) were purchased from
Dharmacon (Chicago, IL). HUVECs were seeded into 6 well
plates for 24 h to reach 50–70% confluence and were transfected
with siRNA at a final concentration of 100 nM using Dharmafect
according to the manufacturer’s protocols. The medium was
replaced 24 h after transfection and cells were irradiated and
processed for further analysis. The silencing efficiency of siRNAs
was confirmed by real time PCR and western blot analyses.
Statistical Analyses
Data are given as means 6 SEM. Statistical analyses were
performed by ANOVA or Student’s t test with a level of
significance of P,0.05. Mouse survival curves were calculated
by the Kaplan-Meier method and compared using the log rank
test.
Results
Overexpression of Molecular Actors of TGF-b/Smad
Signaling in Mouse Radiation Enteropathy is Associated
with Increased Expression of Smad co-repressors TGIF1
and SnoN
We used an in vivo model of radiation enteropathy to investigate
the kinetics of mRNA levels of TGF-b1 itself, an effector of Smad
signaling, Smad3, and a TGF-b1/Smad-target gene, PAI-1.
During the observation period (days 1, 3, 14 and 42 after
irradiation), mRNA levels of TGF-b1, Smad3 and PAI-1 increased
progressively to reach a peak at 14 days, compared to control
levels in sham-operated mice for each time point (Figure 1).
Expression of TGF-b1 and Smad3 decreased to control levels by
42 days, whereas PAI-1 expression was still 2.5 times greater
compared to the control level (Figure 1). These observations
provide strong evidence that our model is appropriate to study
a putative implication of Smad co-repressors and inhibitors in the
radiation-induced TGF-b/Smad activation pathway. To investi-
gate whether TGF-b-signaling pathway activation in mouse
irradiated intestine could be related to aberrant regulation of
Smad transcriptional co-repressors/inhibitors, (ie TGIF1, SnoN,
Ski and Smad7), kinetic analysis of their transcript levels in
irradiated intestinal tissues was performed. Figure 2 shows that the
kinetics of TGIF1 and SnoN gene expression follows the same
pattern of variation as TGF-b1, Smad3 and PAI-1 mRNA levels.
No variations were observed for Ski and Smad7. In our model of
radiation enteropathy, up-regulation of TGF-b signaling tran-
scripts (TGF-b1 and Smad3) and the TGF-b1 downstream target
gene PAI-1 is associated with an increased expression of the Smad
co-repressors TGIF1 and SnoN.
Expression of TGF-b/Smad Regulatory Elements and PAI-
1 in a Radiation Dose - and Time-dependent Manner in
Endothelial Cells
Previous studies from our group showed that radiation-induced
rectal damage in humans is associated with overexpression of PAI-
1 and phospho–Smad2/3 in the endothelium [14]. TGIF1
immunohistochemical staining performed on human rectum
sections revealed a positive immunoreactivity in the smooth
muscle layers and endothelium of submucosal vessels (Figure S2).
Even if it was not possible to ascertain differences in TGIF1
staining intensity between unexposed and irradiated tissues in the
endothelial compartment, this observation comforted us in the
choice of human endothelial cells for in vitro studies. We then used
Human Umbilical Endothelial Cells (HUVECs) to investigate
whether the expression of TGF-b/Smad co-repressors and
inhibitors is modulated in response to ionizing radiation. Time-
course and dose-response experiments in HUVECs revealed that
Smad3 and PAI-1 transcript levels, as well as their protein
abundance, increased after irradiation (figure 3A). Moreover, the
phosphorylated form of Smad3 increased rapidly after irradiation,
demonstrating an activation of TGF-b/Smad pathway signaling in
this in vitro model. Radiation exposure did not affect Ski, SnoN,
and Smad7 mRNA and protein expression in either a dose- or
time- dependent manner. Interestingly, and in accordance with in
vivo results, after irradiation TGIF1 expression increased at both
the mRNA and protein levels (figure 3B), suggesting that TGIF1
could affect the normal tissue response to ionizing radiation.
TGIF1 Genetic Deficiency Sensitizes Mice to Radiation-
induced Intestinal Damage
To prove the involvement of TGIF1 in radiation-induced
intestinal damage, we followed the survival of TGIF1 deficient
mice under two irradiation conditions: a radiation–induced lethal
gastrointestinal syndrome after 13 Gy total body irradiation (TBI),
and localized radiation-induced enteropathy after 19 Gy irradia-
tion. After a lethal 13 Gy TBI, Kaplan-Meier curves show that
homozygous and heterozygous TGIF1 deficient mice died more
rapidly than TGIF1
+/+ mice. Eight days after irradiation, no
TGIF1
2/2 mice survived whereas 100% lethality in TGIF1
+/2
and TGIF1
+/+ mice occurred at 10 and 13 days, respectively
(figure 4A). After a 13 Gy TBI and without bone marrow
transplantation, the cause of death is due to both bone marrow
destruction and gastrointestinal damage. Survival curves obtained
after TBI irradiation suggest that TGIF1 plays a role in radiation-
induced gastrointestinal damage, but one may not exclude a role
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model of localized radiation enteropathy, Kaplan-Meier analyses
show that 40% of TGIF1
+/+ died rapidly in the first 10 days
(figure 4B). At day 10, lethality is more pronounced in TGIF1
+/2
(70%) and TGIF1
–/– (84%) mice. Fifty days after irradiation, no
TGIF1
2/2 mice survived whereas 58% of TGIF1
+/+ and 21% of
TGIF1
+/2 were still alive (figure 4B). Three days after 19 Gy
localized small intestinal irradiation, histological examination
(Figure S3) revealed mucosal inflammatory infiltrate (A) and
significant crypt loss in all tissues (B). Crypt loss was significantly
more severe in TGIF1
2/2 mice than in other groups. No
significant change in villus height was observed at this time point
in any group (C).
TGIF1 Deficiency is not Associated with Changes in
Radiation-induced TGF-b Pathway-Related Transcripts in
Mouse Radiation Enteropathy
TGIF1-deficient mice showed an enhanced sensitivity to TBI
and localized intestinal radiation exposure, thus we examined
whether the exacerbated radiosensitivity of TGIF1 deficient mice
is associated with a deleterious role of TGF-b/Smad pathway
signaling activation in radiation intestinal damage. We studied the
acute effect of 19 Gy localized intestinal radiation on TGF-b/
Smad signaling-related transcripts (TGIF1, TGF-b1, Smad3,
Smad7, Ski and SnoN) and Smad-target gene-related transcripts
(PAI-1, CTGF, COL3AI, MMP2 and MMP9) at day 3 in
TGIF1
+/+, TGIF1
+/2 and TGIF1
2/2 mice. Consistent with our
previous data, irradiation increased expression of TGF-b1, Smad3
and TGIF1. No significant variation was observed for Smad7, ski
and SnoN (figure 5A). In addition, comparisons of mRNA
expression profiles of intestinal sections of irradiated TGIF1
2/2
and TGIF1
+/2 versus irradiated TGIF1
+/+ mice showed that
TGIF1 deficiency did not alter radiation-induced TGF-b1 and
Smad3 expression. In a similar fashion, we showed that the lack of
TGIF1 did not modify the radiation-induced up-regulation of
TGF-b/Smad target genes such as PAI-1, CTGF, COL3AI,
MMP2 and MMP9 (figure 5B). All together, these results suggest
that the influence of TGIF1 on radiation-induced intestinal
sensitivity in vivo is independent of the TGF-b/Smad canonical
pathway.
Radiation-induced TGF-b/Smad Pathway Activation in
HUVECs is Independent of TGIF1
By using the TGF-b/Smad responsive gene reporter vector
(CAGA9-luc), radiation-induced Smad-dependent transcription
was measured in HUVECs after 10 Gy exposure in the presence
or absence TGF-b1. Results showed that both irradiation and
TGF-b1 activate Smad-dependent transcription in HUVECs
(figure 6A). Next, we investigated the impact of TGIF1 over-
expression on TGF-b1 - and radiation-induced Smad transcrip-
tion. Luciferase activity in HUVECs transfected with myc-Smad3,
with or without myc-TGIF1, and with or without treatment with
TGF-b1 and/or irradiation, showed that overexpression of TGIF1
represses the TGF-b-induced SMAD-dependent transcriptional
activation but not the radiation-induced SMAD-dependent
transcription (figure 6B). To confirm these results, we examined
whether TGIF1 overexpression affects radiation-induced Smad-
dependent transcription of PAI-1. A PAI-1 promoter-luciferase
Figure 1. Radiation induces activation of the TGF-b pathway in a mouse model of 19 Gy-localized small intestinal irradiation: mRNA
levels measured by real time PCR of TGF-b1, SMAD3 and PAI-1 in total intestinal tissues, 5 hours, 1 day, 3 days, 14 days and
42 days after irradiation. mRNA level of 18S was used as housekeeping gene and dot line indicates value 1 assigned for control sham-operated
animals at each time. Results are +/2 SEM (n=6 to 8 mice/group). *p,0.05 versus sham mice.
doi:10.1371/journal.pone.0035672.g001
Figure 2. Kinetic analyses of mRNA levels of SMAD co-repressors and inhibitors in a mouse model of 19 Gy-localized small
intestinal irradiation: mRNA levels of TGIF1, SnoN, Ski and SMAD7 were measured by real time PCR in total intestinal tissues,
5 hours, 1 day, 3 days, 14 days and 42 days after irradiation. mRNA level of 18S was used as housekeeping gene and dot line indicates value
1 assigned for control sham-operated animals at each time. Results are +/- SEM (n=6 to 8 mice/group). *p,0.05 versus sham mice.
doi:10.1371/journal.pone.0035672.g002
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myc-Smad3 with or without myc-TGIF1, and with Wt-PAI-Luc
gene reporter vector or CAGA box-mutated PAI-1 Luc gene
reporter (Db123-PAI-1 Luc). Radiation increased luciferase
activity in HUVECs transfected with Wt-PAI-1-luc but not with
Db123-PAI-1 Luc. Radiation-induced, Smad-dependent PAI-1
transcription was not influenced by TGIF1 over-expression
(Figure 6C). Western blot experiments performed on HUVECs
cotransfected with myc-Smad3 with or without myc-TGIF1
confirmed that TGIF1 overexpression has no effect on radiation-
induced PAI-1 protein expression (figure 6D). To complete these
results, TGIF1 expression knock-down was performed using
TGIF1 siRNA in HUVECs to explore the impact of TGIF1
silencing on radiation-induced Smad3 and PAI-1 expressions.
Silencing efficiency (90%) was confirmed by real time PCR (data
not shown) and western blot (figure 6E). TGIF1 knock down had
no effect on radiation-induced mRNA levels of Smad3 and PAI-1,
and had no effect on either PAI-1 protein level or the
phosphorylated form of Smad3 (figure 6F and G).
Figure 3. Effect of irradiation on mRNA and protein expression of SMAD3, PAI-1 and SMAD co-repressors and inhibitors in HUVEC.
(A) Irradiation induces SMAD pathway and PAI-1 in HUVEC cells. mRNA levels of SMAD3 and PAI-1 in HUVEC 6, 24, 48 and 72 hours after irradiation
were measured by real time PCR. mRNA level of GAPDH was used as housekeeping gene and value 1 was assigned to unirradiated cells for each time.
Protein levels of Smad3, phospho-Smad3 and PAI-1 were followed by western blot. (B) Radiation dose- and time-dependent mRNA level and protein
abundance of TGIF1, SnoN, Ski and Smad7 were measured by real time PCR and western blot. Results are the mean 6 SEM of 3 independent
experiments realized in triplicates. *P,0.05 vs unirradiated cells.
doi:10.1371/journal.pone.0035672.g003
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Increased expression, secretion, and activation of TGF-b1 and
Smad following radiation exposure [13,14,36–38] strongly sug-
gests that TGF-b/Smad-dependent signaling is involved in the
initiation and progression of radiation-induced normal tissue
injury. In irradiated tissues, TGF-b1 cytokine production may
result from transcriptional, translational and/or post translational
mechanisms [37,39,40]. In addition to TGF-b1 itself, irradiation
also induces the up-regulation of TGF-b receptors, activation of
Smad2/3, and the subsequent increase in expression of Smad
target genes, such as PAI-1 and CTGF, in different in vivo and in
vitro models [13,14,17,38]. Despite all of these extended studies of
TGF-b signaling activation after irradiation, the role of Smad
inhibitors and co-repressors has never been investigated in the
context of radiation-induced normal tissue injury.
Here we show for the first time that the Smad co-repressor
TGIF1 plays a role in radiation-induced intestinal damage and,
unexpectedly, we demonstrate that radiation-induced Smad
signaling in endothelial cells is independent of TGIF1.
On the basis of previous studies showing that downregulation of
Smad inhibitors and Smad co-repressors amplifies TGF-b signaling
activation and contributes to the progression of fibrosis [31,32], we
hypothesized that Smad co-repressors and I-Smad down-regula-
tion could be responsible in part for radiation-induced activation
of TGF-b signaling and downstream target genes expression. In
our experimental model of mouse radiation enteropathy, activa-
tion of the pro-fibrosing TGF-b/Smad pathway and its target gene
PAI-1 is associated with increased expressions of two Smad co-
repressors, mainly TGIF1 and to a lesser extend SnoN.
To investigate the in vitro expression of TGF-b/Smad co-
repressors and inhibitors in response to ionizing radiation, we
chose endothelial cells for two reasons: 1) for the positive
immunoreactivity of TGIF1 phospho-Smad2/3 and PAI-1 in the
endothelium of submucosal vessels of human irradiated normal
rectum and 2) for the activation of TGF-b signaling in response to
irradiation previously shown by our group and others [14,38].
Kinetic analysis of transcriptional levels of Smad co-repressors/
inhibitors in HUVECs shows an increase in TGIF1 expression
after irradiation. Our in vivo and in vitro results show that TGIF is
Figure 4. TGIF1 genetic deficiency sensitizes mice to gastrointestinal syndrome and radiation enteropathy. Kaplan-Meier analyses
represent the percent survival of TGIF1
+/+, TGIF1
+/2 and TGIF1
2/2 mice following (A) 13 Gy total body irradiation and (B) 19 Gy localized small
intestinal irradiation. Statistical differences were determined by the log rank test, *p=0.0033, **p=0.19, ***p=0.00065,
#p=0.06,
##p=0.11,
###p=0.000014.
doi:10.1371/journal.pone.0035672.g004
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deficiency in mice enhanced radiation sensitivity in cases of either
TBI or localized high dose intestinal radiation exposure,
demonstrating the principle that TGIF1 modulation affects the
normal tissue response to ionizing radiation.
Proliferation and apoptosis are two crucial events in the
intestinal tissue response to high dose radiation exposure. TGIF1
genetic deficiency is associated with the deregulation of fibroblast
proliferation and progression through the G1 cell cycle phase [35],
and down-regulation of TGIF1 sensitizes HepG2 cells to arsenic
trioxide-induced apoptosis [41]. Changes in cell proliferation and/
or apoptosis in radiosensitive compartments could explain the
enhanced radiosensitivity of TGIF1 deficient mice. TGIF1
deficient irradiated intestine does not show any detectable
variation in the expression of the principle G1 cell cycle regulatory
genes (i.e. p21, cylin D, p27 and p15) (data not shown). However,
crypt loss is more severe in TGIF1
2/2 mice than in other groups
and may reflect either increased radiation-induced cell loss and/or
reduced regenerative cell proliferation. The measure of the
Figure 5. TGIF1 genetic deficiency is not associated with modifications of radiation-induced TGF-b pathway-related molecular
profile in vivo. mRNA levels of (A) TGF-b signaling-related genes and (B) TGF-b/Smad target genes in TGIF1
+/+, TGIF1
+/2 and TGIF1
2/2 mice 3 days
after 19 Gy localized small intestinal irradiation were determined by real time PCR. mRNA level of 18S was used as housekeeping gene and value 1
was assigned to sham-operated TGIF1
+/+ animals. Results are the mean 6 SEM with 8 to 10 mice per group. *P,0.05 vs TGIF1
+/+ sham mice.
#P,0.05
vs TGIF1
+/+ irradiated mice. No significant difference was obtained between TGIF1
+/+, TGIF1
+/2 and TGIF1
2/2 sham-irradiated animals.
doi:10.1371/journal.pone.0035672.g005
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endothelial cells will be a promising continuation of this work.
TGIF1 exerts several different modes of TGF-b/Smad de-
pendent transcriptional repression. TGIF1 replaces the co-
activators that bind to Smad2 and Smad3, and also recruits other
Figure 6. TGIF1 has no effect either on radiation-induced Smad pathway activation or on radiation-induced PAI-1 overexpression
in endothelial cells. (A) HUVECs were transfected with (CAGA)9-Luc reporter plasmid for 24 h and were serum starved for 18 hours. Cells were
irradiated at 10 Gy in presence or not of 10 ng/mL TGF-b1. Relative luciferase activity was measured 24 h after irradiation (B) HUVECs were co-
transfected for 24 h with CAGA9-Lux and myc-Smad3 with or without myc-TGIF1. Relative luciferase activity was measured 24 h after irradiation and/
or treatment with 10 ng/mL of TGF-b1. (C) HUVECs were transfected with wt-PAI-1 Luc reporter or CAGA box-mutated PAI-1 Luc reporter (D123-PAI-1
Luc) and myc-Smad3 with or without myc-TGIF1. Luciferase activity was assayed 24 hours after irradiation. Relative luciferase activity is the mean 6
SEM of at least 3 independent experiments realized in triplicates (D) HUVECs were transfected for 24 h with myc-Smad3 with or without myc-TGIF1.
Cells were irradiated at 10 Gy and PAI-1 expression was measured 24 h after irradiation. E-G) HUVECs were transfected with non–targeting siRNA
(siRNA control) or siRNA TGIF1 for 24 h and irradiated at 10 Gy. Silencing efficiency was confirmed by western-blot (E). mRNA level (F) and protein
levels of PAI-1 and Phospho-Smad3 were performed by western-blots (G). Results are the mean +/- SEM of two independent experiments realized in
triplicates and representative blots from three independent experiments are shown. *p,0.05
doi:10.1371/journal.pone.0035672.g006
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Sin3, to the complex, thus repressing TGF-b/Smad target genes
[30]. In addition, TGIF1 may also regulate ubiquitin-dependant
degradation of Smad2 [42], and by recruiting carboxyl-terminus
binding protein, can also repress TGF-b1 gene transcription via
interactions with polycomb group proteins [43]. We examined
whether the exacerbated radiosensitivity of TGIF1 deficient mice
is associated with the deleterious role of TGF-b/Smad signaling
activation reported in diverse irradiated tissues. Analyses after
19 Gy localized intestinal irradiation reveals that TGIF1 de-
ficiency does not alter the expression of either radiation-induced
TGF-b1 signaling gene expression (TGF-b1, Smad3, Smad7, Ski
and SnoN) or radiation-induced TGFb/Smad target gene (PAI-1,
CTGF, COL3AI, MMP2 and MMP9). These in vivo results suggest
that TGIF1 exerts a role in radiation-induced injury without
altering Smad target gene transcription. In vitro, overexpression of
TGIF1 in HUVECs represses TGF-b1-induced SMAD-depen-
dent transcriptional activation, showing that TGIF1 is a key
regulator of TGF-b1 signaling in endothelial cells. However,
TGIF1 overexpression affects neither the radiation-induced Smad-
dependent transcription, nor the radiation-induced Smad-de-
pendent PAI-1 overexpression. In support of these results, TGIF1
silencing in HUVECs has no effect on radiation-induced PAI-1
expression. Altogether, our in vivo and in vitro results show that
TGIF1 plays a role in radiation-induced injury independently of
a Smad signaling pathway. Moreover, our experiments reveal
differences between the TGF-b1 and the radiation-induced Smad-
dependent transcription in endothelial cells, and molecular
mechanisms involved in these differences will have to be
elucidated.
Moreover, TGIF1 has been reported to interact with Ras/
MAPKinase, ERK1/2 and NF-kb pathway and thereby con-
tributes to inflammation, differentiation and apoptosis in response
to a variety of growth factors (EGF and HGF) and cytokines (TNF-
a) [44–46]. Irradiation activates MAPKinase and NF-kb pathways
in different tissues and in endothelial cells [47,48], and it would be
interesting to explore whether TGIF1 genetic deficiency is
associated with a deregulation in one or more of these pathways
that could contribute to the sensitization of TGIF1 deficient mice
to radiation damage.
In conclusion, this is the first report which shows that TGIF1 is
increased in response to ionizing radiation, and that this protein
plays a role in radiation injury. The molecular mechanism by
which TGIF1 is involved in radiation-induced intestinal damage
seems to be independent of TGF-b/Smad signaling and future
investigations to understand the role of TGIF1 in radiation-
induced injury need to be performed.
Supporting Information
Figure S1 Example of PCR screening for TGIF1 geno-
type.
(TIF)
Figure S2 Representative microscopic images from
immuno-labelling of TGIF1 on human rectal tissue
submucosal vessels. (A) unirradiated tissue; (B) dystrophic
vessel in the irradiated area from the same patient. Magnification
x 200.
(TIF)
Figure S3 Radiation-induced small intestinal damage.
(A) Images of small intestinal tissues obtained 3 days after sham or
19 Gy localized small intestinal irradiation in wild type, TGIF1
+/
+, TGIF1
+/- and TGIF1
2/2 animals. Left panel magnification x40
and right panel magnification x200 as indicated. (B) Number of
surviving crypts measured in small intestinal sections 3 days after
sham or 19 Gy localized small intestinal irradiation in wild type,
TGIF1
+/+, TGIF1
+/2 and TGIF1
2/2 animals. (C) Villus height
measured in small intestinal sections 3 days after sham or 19 Gy
localized small intestinal irradiation in wild type, TGIF1
+/+,
TGIF1
+/2 and TGIF1
2/2 animals. The hatched bars represent
the wild type control values. *p,0.001 compared to sham animals;
#p,0.005 and
##p,0.001 between irradiated groups.
3,n,6 per group.
(TIF)
Table S1 List of Pre-developped TaqMan gene expres-
sion assay used to quantify transcripts levels.
(TIF)
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